A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain
Frontiers in Public Health · 24.06.2026 · 14
DOI: 10.3389/fpubh.2026.1829029 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Frontiers in Public Health, online erschienen am 24.06.2026. Verfasst von Serafín Sánchez-Gómez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Head and Neck Surgery, Hospital Universitario Virgen Macarena, Sevilla, Spain. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Hearing Aids, Bone Conduction, Hearing Loss. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the cost-effectiveness of the transcutaneous bone-conduction hearing implant Osia® System compared to the percutaneous bone-conduction hearing implant Baha® Connect System in a pooled population of adults eligible for bone-conduction hearing implants, from the perspective of the Spanish National Health System.
Methods
A lifetime Markov model with 6-month cycles was simulated based on a previously published Swedish study, incorporating three primary health states: “with implant,” “without implant,” and “dead.” Clinical inputs included probabilities of adverse events (e.g., complications, device failure), health utilities in Quality-Adjusted Life Years (QALYs), and direct healthcare costs. Costs and QALYs were discounted at a 3% annual rate. Deterministic and probabilistic sensitivity analysis were conducted to assess the uncertainty of the model parameters.
Results
In the base-case analysis, the Osia® System incurred a total cost of €24,555 per patient and yielded 15.94144 QALYs, while the Baha® Connect System accounted for €20,968 and generated 15.17033 QALYs. The incremental cost-effectiveness ratio (ICER) of the Osia® System was €4,651/QALY gained, compared to the Baha® Connect System. The model was most sensitive to utility values for each device. At a willingness-to-pay threshold of €30,000/QALY, the probabilistic sensitivity analysis showed that the Osia® System had a 62% probability of being cost-effective.
Conclusion
From the Spanish healthcare system perspective, the Osia® System is a cost-effective alternative to the Baha® Connect System for the overall adult patient population with hearing loss in Spain eligible for a bone-conduction hearing implant. These results support its inclusion in national coverage and reimbursement policies to improve clinical and patient-reported outcomes and to promote sustainable healthcare delivery. However, these findings should be interpreted cautiously due to the reliance on non-Spanish clinical inputs and the absence of subgroup-specific analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology and Head and Neck Surgery, Hospital Universitario Virgen Macarena, Sevilla, Spain.
- Department of Otolaryngology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
- Axentiva Solutions S.L., Barcelona, Spain.
- Axentiva Solutions S.L., Oviedo, Spain.
Zitieren
APA
Sánchez-Gómez, S., Polo, R., Ibáñez-Ortigosa, F., Martínez-Pérez, Ó., Zamora, V., & Cuervo, J. (2026). A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1829029
Vancouver
Sánchez-Gómez S, Polo R, Ibáñez-Ortigosa F, Martínez-Pérez Ó, Zamora V, Cuervo J. A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1829029
BibTeX
@article{SnchezGmez2026,
author = {Sánchez-Gómez, Serafín and Polo, Rubén and Ibáñez-Ortigosa, Francisco and Martínez-Pérez, Óscar and Zamora, Víctor and Cuervo, Jesús},
title = {A cost-utility analysis of the transcutaneous Osia System® compared to the percutaneous bone-conduction hearing implant Baha® Connect for hearing loss in Spain},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1829029}
}
EUVIMED